The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Cefminox from Two Different Manufacturers for Urinary System Infection: Cost-effective Analysis
Author(s): 
Pages: 293-294
Year: Issue:  4
Journal: EVALUATION AND ANALYSIS OF DRUG-USE IN HOSPITAL OF CHINA

Keyword:  不同厂的头孢米诺钠泌尿系感染成本-效果分析;
Abstract: 目的:分析不同厂生产的头孢米诺钠治疗泌尿系感染的疗效和用药费用,从而指导临床更合理选择和应用药物.方法:将64例随机分为A组和B组各32例,分别给予静脉滴注进口的头孢米诺钠1g和国产的头孢米诺钠1g,bid,连续用药7d.结果:A组临床有效率为93.8%,B组为90.6%,两组安全性较好;A组药费为1 820.0元,B组药费为1 030.4元,B组要比A组节省789.6元.结论:在两组治疗效果无显著性差异情况下,B组治疗泌尿系感染是一种经济有效的治疗方案.
Related Articles
loading...